Open AccessANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS AS A RISK FACTOR FOR PATIENTS HOSPITALIZED WITH COVID-19. IS THAT TRUE?
Author(s) -
Paula Luque,
Luis Castilla-Guerra,
Maria Ferrary,
Nieves Sánchez,
María Alegre,
Eduardo Alejandro Carmona,
Miguel Ángel Rico
Publication year - 2022
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000837064.52633.a5
Subject(s) - medicine , angiotensin converting enzyme , angiotensin receptor blockers , logistic regression , cohort study , angiotensin receptor , population , covid-19 , cohort , risk factor , retrospective cohort study , angiotensin ii , receptor , blood pressure , disease , environmental health , infectious disease (medical specialty)